Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 15, 2020
Product Development
Celltrion launches antigen and serology COVID-19 tests in the U.S., Verily adds capacity with CLIA lab and more
COVID-19 diagnostic developments this week include the addition of two types of COVID-19 rapid test kits by Celltrion and Verily’s move to boost capacity with a new CLIA lab in South San
BioCentury | Jan 25, 2018
Company News
Novartis gains ex-U.S. rights to Spark's gene therapy, and reports earnings
Items per page:
1 - 10 of 50